Manufacturer record

Sotac Pharmaceuticals Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Sotac Pharmaceuticals Pvt. Ltd (Gujarat) were declared Not of Standard Quality between April 2021 and October 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Sotac Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2021 to Oct 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2021
3
Products affected
Dissolution
Most common failure
Oct 2025
Latest alert

Flagged batches per year

2021 · 12025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Khasigo-LS Syrup (Levosalbutamol Sulphate, Ambroxol Hydrochloride Guaiphenesin Syrup) SP244505Mfg 2024-12 · Exp 2026-11 ContentOther Drugs Testing Laboratory, Madurai-19State lab Oct 2025
Montelukast Sodium and Levocetirizine hydrochloride Tablets IP (10mg+5mg) (MONTLEVO) SP240802Mfg 2024-04 · Exp 2026-03 The sample does not conform as per IP 2022 in respect to the description, as out of 40 Tablets 15 were found moistened, bulged and crackedDescription Government Analyst, DTL, Baddi, Distt Solan, Himanchal PradeshState lab Jul 2025
Paracetamol Tablets IP 650 mg (MECIPAR 650 TABLETS) SP20641Mfg 2020-07 · Exp 2022-06 DissolutionDissolution RDTL ChandigarhCDSCO lab Apr 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.